1.
Yıldız A, Okutur K, Eren N. Assessment of thrombin-activatable fibrinolysis inhibitor levels in essential hypertension. Eur Res J [Internet]. 2025 Jan. 3 [cited 2026 May 22];11(1):1-10. Available from: https://www.eurj.org.tr/article/view/1023